双重问题:癌症中的细胞质和核IKKα
Kirsty Tinto1, Margaret Cunningham1, Robin Plevin1
1Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, UK.
Open biology
|August 5, 2025
概括
IκB激酶α (IKKα) 在炎症和癌症中起着双重作用. 这次审查强调了IKKα.
科学领域:
- 分子生物学分子生物学
- 癌症研究 癌症研究
- 免疫学 免疫学 免疫学
背景情况:
- IκB激酶α (IKKα) 是一种氨酸/氨酸激酶,参与激活B细胞 (NF-κB) 信号的核因子卡帕光链增强剂.
- IKKα参与了正规和非正规的NF-κB通路,并调解了NF-κB独立的效应.
- 一种核活性异型,p45-IKKα,已与癌症和化学抵抗有关.
研究的目的:
- 审查核和细胞质IKKα在促进瘤进展中的复杂作用.
- 突出 IKKα 在各种癌症亚型中的分子功能.
- 探索向IKKα在癌症治疗中的治疗潜力.
主要方法:
- 关于IKKα的现有研究的文献综述.
- 对IKKα在癌症特征中的分子作用的分析.
- 讨论IKKα在不同类型癌症中的参与.
主要成果:
- IKKα在细胞质和细胞核之间表现出动态的穿,调解各种信号通路.
- IKKα与多种癌症特征有关,包括炎症和瘤进展.
- 这种p45-IKKα异型有助于癌症的发展和化学抵抗.
结论:
- IKKα在癌症中具有多方面的作用,通过NF-κB依赖和独立的机制起作用.
- 了解IKKα的核和细胞质功能对于癌症研究至关重要.
- IKKα代表了开发新型抗癌药物的有前途的治疗标.
相关概念视频
NF-κB-dependent Signaling Pathway
7.9K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.9K
The Intrinsic Apoptotic Pathway
6.9K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.9K
Induced Pluripotent Stem Cells
4.4K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.4K
Cancer Cell Migration through Invadopodia
2.4K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.4K
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
Inhibition of Cdk Activity
4.9K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K


